Balance Sheet MannKind Corporation

Equities

MNKD

US56400P7069

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 10/04/2026 BST			5-day change	1st Jan Change
2.570 ^USD	+0.39%		+2.80%	-54.67%

03-11	MannKind Corporation Presents at Barclays 28th Annual Global Healthcare Conference, Mar-11-2026 01:00 PM
03-09	MannKind Corporation to Present New Data from Pediatric and Adult Studies of Afrezza at ATTD 2026	CI

23c2e820b6aff4c7da.UZqqPOqc8hoh7M8B-xkCj2fuJwZI_7BUWdFLVFBXu6o.HPDrZtqxpVJvlLpmo0FOxBTeEVIAsvgMA4YnIjMcg_oW2d8PoMrCVEye-w

Published financial data: MANNKIND CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	75.44M	99.77M	199M	286M	349M
Other Revenues, Total	-	-	-	-	-
Total Revenues	75.44M	99.77M	199M	286M	349M
Cost of Goods Sold, Total	38.86M	57.5M	62.77M	76.6M	87.96M
Gross Profit	36.58M	42.27M	136M	209M	261M
Selling General & Admin Expenses, Total	77.42M	91.47M	94.31M	94.33M	144M
Provision for Bad Debts	100K	-	-	-	-
R&D Expenses	12.31M	19.72M	31.28M	45.89M	66.35M
Amortization of Goodwill and Intangible Assets - (IS)	-	-	-	-	3.97M
Other Operating Expenses, Total	89.83M	111M	126M	140M	214M
Operating Income	-53.24M	-68.92M	10.59M	68.68M	46.55M
Interest Expense, Total	-16.58M	-24.77M	-25.16M	-37.98M	-38.03M
Interest And Investment Income	112K	2.51M	6.15M	12.62M	8.05M
Net Interest Expenses	-16.46M	-22.26M	-19.01M	-25.37M	-29.98M
Currency Exchange Gains (Loss)	6.57M	4.81M	-1.92M	3.91M	-7.75M
Other Non Operating Income (Expenses)	-578K	-102K	122K	32K	-1.01M
EBT, Excl. Unusual Items	-63.72M	-86.47M	-10.21M	47.25M	7.82M
Restructuring Charges	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-932K	-170K	-1.55M	-6.41M
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	-6K	-	-	-	-
In Process R&D Expenses	-	-	-	-	-
Other Unusual Items	-17.2M	-	-	-15.18M	-
EBT, Incl. Unusual Items	-80.93M	-87.4M	-10.38M	30.52M	1.41M
Income Tax Expense	-	-	1.56M	2.93M	-4.46M
Earnings From Continuing Operations	-80.93M	-87.4M	-11.94M	27.59M	5.86M
Net Income to Company	-80.93M	-87.4M	-11.94M	27.59M	5.86M
Net Income - (IS)	-80.93M	-87.4M	-11.94M	27.59M	5.86M
Net Income to Common Incl Extra Items	-80.93M	-87.4M	-11.94M	27.59M	5.86M
Net Income to Common Excl. Extra Items	-80.93M	-87.4M	-11.94M	27.59M	5.86M
Per Share Items
Net EPS - Basic	-0.32	-0.34	-0.04	0.1	0.02
Basic EPS - Continuing Operations	-0.32	-0.34	-0.04	0.1	0.02
Basic Weighted Average Shares Outstanding	249M	257M	267M	274M	274M
Net EPS - Diluted	-0.32	-0.34	-0.04	0.1	0.02
Diluted EPS - Continuing Operations	-0.32	-0.34	-0.04	0.1	0.02
Diluted Weighted Average Shares Outstanding	249M	257M	267M	284M	314M
Normalized Basic EPS	-0.16	-0.21	-0.02	0.11	0.02
Normalized Diluted EPS	-0.16	-0.21	-0.02	0.1	0.02
Supplemental Items
EBITDA	-49.41M	-63.23M	15.13M	76.05M	58.83M
EBITA	-53.24M	-68.92M	10.59M	68.68M	50.55M
EBIT	-53.24M	-68.92M	10.59M	68.68M	46.55M
EBITDAR	-48.03M	-61.43M	16.91M	78.39M	62.57M
Total Revenues (As Reported)	75.44M	99.77M	199M	286M	349M
Effective Tax Rate - (Ratio)	-	-	-15.04	9.6	-316.7
Current Domestic Taxes	-	-	1.56M	2.75M	493K
Current Foreign Taxes	-	-	-	165K	-
Total Current Taxes	-	-	1.56M	2.92M	493K
Deferred Domestic Taxes	0	0	6K	15K	-4.95M
Total Deferred Taxes	0	0	6K	15K	-4.95M
Normalized Net Income	-39.82M	-54.04M	-6.38M	29.53M	4.88M
Interest on Long-Term Debt	16.58M	24.77M	24.98M	21.81M	23.58M
Supplemental Operating Expense Items
Selling and Marketing Expenses	-	53.75M	51.78M	-	-
General and Administrative Expenses	-	35.92M	40.76M	-	-
Research And Development Expense From Footnotes	12.31M	19.72M	31.28M	45.89M	66.35M
Net Rental Expense, Total	1.38M	1.8M	1.78M	2.34M	3.74M
Imputed Operating Lease Interest Expense	722K	928K	939K	2.67M	3.64M
Imputed Operating Lease Depreciation	656K	871K	840K	-331K	98.42K
Stock-Based Comp., COGS (Total)	2.12M	1.75M	2.49M	4.06M	3.66M
Stock-Based Comp., R&D Exp. (Total)	614K	1.04M	1.44M	2.24M	2.48M
Stock-Based Comp., S&M Exp. (Total)	-	1.19M	2.29M	-	-
Stock-Based Comp., G&A Exp. (Total)	-	9.46M	11.43M	-	-
Stock-Based Comp., SG&A Exp. (Total)	9.47M	-	-	15.06M	18.06M
Total Stock-Based Compensation	12.2M	13.45M	17.65M	21.36M	24.2M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	124M	69.77M	238M	46.34M	74.88M
Short Term Investments	79.93M	101M	63.52M	157M	96.46M
Total Cash And Short Term Investments	204M	171M	302M	204M	171M
Accounts Receivable, Total	4.74M	16.8M	14.9M	35.86M	68.57M
Other Receivables	255K	-	-	1M	700K
Total Receivables	4.99M	16.8M	14.9M	36.86M	69.27M
Inventory	7.15M	21.77M	28.54M	27.89M	35.31M
Prepaid Expenses	3.48M	25.48M	27.95M	-	15.65M
Restricted Cash	-	-	-	-	-
Other Current Assets, Total	-	-	-	-	-
Total Current Assets	220M	235M	373M	268M	292M
Gross Property Plant And Equipment	134M	144M	190M	205M	208M
Accumulated Depreciation	-97.66M	-98.56M	-102M	-107M	-114M
Net Property Plant And Equipment	36.61M	45.13M	88.9M	98.47M	94.24M
Long-term Investments	59.62M	9.06M	7.16M	5.48M	5.01M
Goodwill	-	2.43M	1.93M	1.93M	67.6M
Other Intangibles, Total	-	1.15M	1.07M	5.26M	325M
Other Long-Term Assets, Total	5.19M	2.62M	2.74M	14.38M	9.05M
Total Assets	321M	295M	475M	394M	792M
Liabilities
Accounts Payable, Total	7.83M	11.05M	9.58M	6.79M	9.03M
Accrued Expenses, Total	21.31M	26.75M	32.18M	31.58M	56.17M
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	-	-	20M	-	36.28M
Current Portion of Leases	6.98M	10.87M	11.23M	12.48M	12.44M
Current Income Taxes Payable	-	-	1.56M	49K	-
Unearned Revenue Current, Total	827K	1.73M	9.08M	12.41M	15.33M
Other Current Liabilities	11.4M	16.9M	20.49M	18.53M	41.77M
Total Current Liabilities	48.35M	67.3M	104M	81.84M	171M
Long-Term Debt	281M	273M	249M	36.05M	318M
Long-Term Leases	94.56M	99.86M	98.24M	106M	104M
Unearned Revenue Non Current	24.49M	37.68M	69.79M	51.16M	39.98M
Other Non Current Liabilities	81.9M	67.5M	201M	198M	210M
Total Liabilities	531M	546M	721M	473M	843M
Common Stock, Total	2.52M	2.64M	2.7M	3.03M	3.08M
Additional Paid In Capital	2.92B	2.96B	2.98B	3.12B	3.14B
Retained Earnings	-3.13B	-3.22B	-3.23B	-3.2B	-3.2B
Comprehensive Income and Other	-	-	-	1.11M	115K
Total Common Equity	-209M	-251M	-246M	-78.82M	-51.02M
Total Equity	-209M	-251M	-246M	-78.82M	-51.02M
Total Liabilities And Equity	321M	295M	475M	394M	792M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	252M	264M	270M	304M	308M
ECS Total Common Shares Outstanding	251M	264M	270M	303M	308M
Book Value / Share	-0.83	-0.95	-0.91	-0.26	-0.17
Tangible Book Value	-209M	-254M	-249M	-86.01M	-443M
Tangible Book Value Per Share	-0.83	-0.96	-0.92	-0.28	-1.44
Total Debt	383M	384M	378M	154M	471M
Net Debt	179M	213M	76.18M	-49.5M	300M
Debt Equivalent Oper. Leases	11.02M	14.39M	14.23M	18.7M	29.9M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	2.7M	5.74M	6.26M	6.18M	14.76M
Inventories - Work In Process, Total	2.52M	13.82M	13.65M	10.66M	11.09M
Inventories - Finished Goods, Total	1.93M	2.22M	8.64M	11.04M	9.47M
Land - (BS)	875K	875K	875K	875K	875K
Buildings, Total	56.04M	56.34M	63.75M	108M	108M
Machinery, Total	66.47M	69.76M	72.14M	76.82M	80.69M
Full Time Employees	348	391	411	403	591
Part Time Employees	1	4	3	4	1
Accumulated Allowance for Doubtful Accounts (Supple)	767K	-	157K	-	61K

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-80.93M	-87.4M	-11.94M	27.59M	5.86M
Depreciation & Amortization - CF	5.1M	8.68M	5.84M	9.04M	8.28M
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	4M
Depreciation & Amortization, Total	5.1M	8.68M	5.84M	9.04M	12.28M
Amortization of Deferred Charges, Total - (CF)	377K	431K	2.08M	1.65M	854K
(Gain) Loss From Sale Of Asset	-	-	-	565K	-
(Gain) Loss on Sale of Investments - (CF)	-	932K	-755K	-3.54M	6.41M
Asset Writedown & Restructuring Costs	106K	-	-	-	-
Stock-Based Compensation (CF)	12.2M	13.45M	17.65M	21.36M	24.2M
Other Operating Activities, Total	19.17M	7.28M	6.59M	22.33M	14.56M
Change In Accounts Receivable	-776K	-11.81M	2.34M	2.65M	-4.76M
Change In Inventories	-4.08M	-5.67M	-11.35M	-3.2M	-6.62M
Change In Accounts Payable	1.37M	4.1M	-1.47M	-2.79M	-16.71M
Change in Unearned Revenues	-9.62M	14.1M	39.46M	-15.31M	-8.26M
Change in Other Net Operating Assets	-4.63M	-24.77M	-14.36M	-17.83M	-9.56M
Cash from Operations	-61.71M	-80.68M	34.09M	42.51M	18.26M
Capital Expenditure	-11.47M	-7.59M	-42.44M	-9.69M	-4.57M
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-	-15.34M	-	-	-348M
Sale (Purchase) of Intangible assets	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-140M	27.8M	40.07M	-87.35M	57.5M
Other Investing Activities, Total	-	-	382K	396K	-10M
Cash from Investing	-152M	4.87M	-1.99M	-96.65M	-305M
Long-Term Debt Issued, Total	332M	-	-	-	325M
Total Debt Issued	332M	-	-	-	325M
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-47.05M	-18K	-6.86M	-134M	-726K
Total Debt Repaid	-47.05M	-18K	-6.86M	-134M	-726K
Issuance of Common Stock	1.99M	22.88M	8.71M	3.14M	1.99M
Repurchase of Common Stock	-498K	-	-10.16M	-6.09M	-3.26M
Other Financing Activities, Total	-16.43M	-1.47M	145M	-752K	-7.9M
Cash from Financing	270M	21.39M	137M	-137M	315M
Net Change in Cash	57.02M	-54.42M	169M	-191M	28.55M
Supplemental Items
Cash Interest Paid	11.27M	8.85M	18.28M	17.51M	14.72M
Cash Income Tax Paid (Refund)	-	-	-	4.26M	1.7M
Levered Free Cash Flow	-68.86M	-75.83M	-23.95M	44.64M	35.57M
Unlevered Free Cash Flow	-58.88M	-60.78M	-10.31M	66.73M	58.48M
Change In Net Working Capital	31.43M	32.24M	-2.02M	-3.1M	2.52M
Net Debt Issued / Repaid	285M	-18K	-6.86M	-134M	324M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-15.49	-13.98	1.72	9.88	4.91
Return on Total Capital	-57.17	-27.93	4.98	41.42	11.75
Return On Equity %	41.53	38.01	4.81	-16.98	-9.03
Return on Common Equity	41.53	38.01	4.81	-16.98	-9.03
Margin Analysis
Gross Profit Margin %	48.49	42.37	68.45	73.17	74.79
SG&A Margin	102.62	91.68	47.4	33.04	41.3
EBITDA Margin %	-65.49	-63.37	7.6	26.64	16.86
EBITA Margin %	-70.58	-69.08	5.32	24.06	14.49
EBIT Margin %	-70.58	-69.08	5.32	24.06	13.34
Income From Continuing Operations Margin %	-107.27	-87.6	-6	9.66	1.68
Net Income Margin %	-107.27	-87.6	-6	9.66	1.68
Net Avail. For Common Margin %	-107.27	-87.6	-6	9.66	1.68
Normalized Net Income Margin	-52.79	-54.17	-3.21	10.34	1.4
Levered Free Cash Flow Margin	-91.28	-76	-12.04	15.64	10.19
Unlevered Free Cash Flow Margin	-78.04	-60.92	-5.18	23.37	16.76
Asset Turnover
Asset Turnover	0.35	0.32	0.52	0.66	0.59
Fixed Assets Turnover	2.41	2.44	2.83	3.05	3.62
Receivables Turnover (Average Receivables)	16.85	9.26	12.55	7.88	6.67
Inventory Turnover (Average Inventory)	6.41	3.98	2.5	2.71	2.78
Short Term Liquidity
Current Ratio	4.54	3.49	3.59	3.28	1.7
Quick Ratio	4.33	2.79	3.04	2.94	1.41
Operating Cash Flow to Current Liabilities	-1.28	-1.2	0.33	0.52	0.11
Days Sales Outstanding (Average Receivables)	21.67	39.4	29.08	46.45	54.74
Days Outstanding Inventory (Average Inventory)	56.95	91.81	146.29	134.81	131.13
Average Days Payable Outstanding	59.65	47.79	54.14	39.45	30.28
Cash Conversion Cycle (Average Days)	18.96	83.42	121.23	141.81	155.59
Long Term Solvency
Total Debt/Equity	-182.83	-153.36	-153.62	-195.47	-922.86
Total Debt / Total Capital	220.74	287.42	286.48	204.75	112.15
LT Debt/Equity	-179.49	-149.02	-140.94	-179.62	-827.37
Long-Term Debt / Total Capital	216.71	279.29	262.82	188.16	100.55
Total Liabilities / Total Assets	165.18	184.85	151.8	120.01	106.44
EBIT / Interest Expense	-3.21	-2.78	0.42	1.81	1.22
EBITDA / Interest Expense	-2.9	-2.48	0.67	2.06	1.65
(EBITDA - Capex) / Interest Expense	-3.59	-2.79	-1.01	1.81	1.53
Total Debt / EBITDA	-7.97	-6.25	22.37	1.97	7.53
Net Debt / EBITDA	-3.72	-3.47	4.51	-0.63	4.79
Total Debt / (EBITDA - Capex)	-6.43	-5.57	-14.81	2.24	8.12
Net Debt / (EBITDA - Capex)	-3	-3.09	-2.98	-0.72	5.16
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	15.81	32.25	99.42	43.5	22.23
Gross Profit, 1 Yr. Growth %	-9.67	15.55	222.17	53.39	24.94
EBITDA, 1 Yr. Growth %	115.71	27.98	-123.06	402.68	-22.64
EBITA, 1 Yr. Growth %	114.82	29.44	-115.37	548.29	-26.4
EBIT, 1 Yr. Growth %	114.82	29.44	-115.37	548.29	-32.22
Earnings From Cont. Operations, 1 Yr. Growth %	41.38	8	-86.34	-331.09	-78.75
Net Income, 1 Yr. Growth %	41.38	8	-86.34	-331.09	-78.75
Normalized Net Income, 1 Yr. Growth %	44.95	35.7	-88.2	-562.95	-83.46
Diluted EPS Before Extra, 1 Yr. Growth %	26.26	4.7	-86.85	-323.67	-80
Accounts Receivable, 1 Yr. Growth %	12.35	254.53	-11.31	-2.01	89.92
Inventory, 1 Yr. Growth %	43.82	204.42	31.11	-2.31	26.63
Net Property, Plant and Equip., 1 Yr. Growth %	41.54	23.25	71.5	10.76	-4.29
Total Assets, 1 Yr. Growth %	195.71	-8.06	60.93	-17.12	101.14
Tangible Book Value, 1 Yr. Growth %	16.03	21.39	-1.95	-65.48	415.41
Common Equity, 1 Yr. Growth %	16.03	19.67	-1.74	-67.98	-35.26
Cash From Operations, 1 Yr. Growth %	119.39	30.74	-142.26	24.69	-57.06
Capital Expenditures, 1 Yr. Growth %	1.33K	-33.81	459.24	-77.16	-52.89
Levered Free Cash Flow, 1 Yr. Growth %	673.62	8.35	-65.5	-286.36	-17.22
Unlevered Free Cash Flow, 1 Yr. Growth %	1.71K	1.3	-81.6	-747.08	-10.11
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	9.4	23.76	62.4	69.16	32.44
Gross Profit, 2 Yr. CAGR %	2.15	2.16	92.94	122.3	38.44
EBITDA, 2 Yr. CAGR %	3.82	66.15	-45.62	7.67	97.2
EBITA, 2 Yr. CAGR %	6.99	66.76	-55.35	-0.18	118.44
EBIT, 2 Yr. CAGR %	6.99	66.76	-55.35	-0.18	109.62
Earnings From Cont. Operations, 2 Yr. CAGR %	24.87	23.57	-61.59	-43.82	-29.92
Net Income, 2 Yr. CAGR %	24.87	23.57	-61.59	-43.82	-29.92
Normalized Net Income, 2 Yr. CAGR %	7.22	40.25	-59.95	-26.08	-12.49
Diluted EPS Before Extra, 2 Yr. CAGR %	10.61	14.98	-62.89	-45.77	-33.12
Accounts Receivable, 2 Yr. CAGR %	16.15	99.58	77.32	46.1	36.87
Inventory, 2 Yr. CAGR %	31.2	109.24	99.78	13.17	11.22
Net Property, Plant and Equip., 2 Yr. CAGR %	16.93	32.08	55.83	37.83	2.96
Total Assets, 2 Yr. CAGR %	85.11	64.89	21.64	15.49	29.11
Tangible Book Value, 2 Yr. CAGR %	4.82	18.68	9.1	-41.82	33.38
Common Equity, 2 Yr. CAGR %	4.82	17.84	8.44	-43.91	-54.47
Cash From Operations, 2 Yr. CAGR %	-16.49	69.36	-25.67	-27.41	-26.83
Capital Expenditures, 2 Yr. CAGR %	111.43	207.81	92.39	13.02	-67.2
Levered Free Cash Flow, 2 Yr. CAGR %	43.11	191.88	-41.69	-19.82	18.68
Unlevered Free Cash Flow, 2 Yr. CAGR %	47.39	332.48	-59.15	9.12	124.41
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	39.38	16.54	45.09	55.84	51.8
Gross Profit, 3 Yr. CAGR %	70.43	6.44	49.81	78.74	83.45
EBITDA, 3 Yr. CAGR %	-14.61	11.32	-12.91	14.13	-3.56
EBITA, 3 Yr. CAGR %	-13.07	14.01	-24.67	8.92	-9.82
EBIT, 3 Yr. CAGR %	-13.07	14.01	-24.67	8.92	-12.26
Earnings From Cont. Operations, 3 Yr. CAGR %	-2.37	18.97	-40.7	-30.14	-59.37
Net Income, 3 Yr. CAGR %	-2.37	18.97	-40.7	-30.14	-59.37
Normalized Net Income, 3 Yr. CAGR %	-9.5	15.98	-38.54	-9.44	-55.12
Diluted EPS Before Extra, 3 Yr. CAGR %	-18.66	8.61	-44.19	-32.47	-61.11
Accounts Receivable, 3 Yr. CAGR %	5.66	68.48	52.3	96.33	59.81
Inventory, 3 Yr. CAGR %	25.75	73.69	79.05	57.39	17.49
Net Property, Plant and Equip., 3 Yr. CAGR %	12.66	19	50.91	39.07	22.05
Total Assets, 3 Yr. CAGR %	43.93	46.6	63.56	7.04	38.95
Tangible Book Value, 3 Yr. CAGR %	6.14	10.08	11.36	-25.66	20.38
Common Equity, 3 Yr. CAGR %	6.14	9.56	10.91	-27.79	-41.17
Cash From Operations, 3 Yr. CAGR %	17.82	-3.03	6.62	-11.68	-39.06
Capital Expenditures, 3 Yr. CAGR %	218.76	43.56	275.59	-5.45	-15.58
Levered Free Cash Flow, 3 Yr. CAGR %	64.25	31.14	39.09	-14.11	-19.99
Unlevered Free Cash Flow, 3 Yr. CAGR %	76.02	30.9	46.95	2.6	1.43
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-15.47	55.02	48.17	35.27	39.89
Gross Profit, 5 Yr. CAGR %	-21.75	47.36	79.1	42.9	45.16
EBITDA, 5 Yr. CAGR %	-5.4	-7.5	-28.21	10.66	20.77
EBITA, 5 Yr. CAGR %	-3.25	-6.25	-33.43	8.11	15.32
EBIT, 5 Yr. CAGR %	-3.25	-6.25	-33.43	8.11	13.43
Earnings From Cont. Operations, 5 Yr. CAGR %	-8.43	-5.72	-32.78	-11.87	-36.6
Net Income, 5 Yr. CAGR %	-8.43	-5.72	-32.78	-11.87	-36.6
Normalized Net Income, 5 Yr. CAGR %	3.02	-5.72	-34.7	-3.14	-29.21
Diluted EPS Before Extra, 5 Yr. CAGR %	-24.91	-21.36	-40.58	-17.73	-40
Accounts Receivable, 5 Yr. CAGR %	73.43	43.21	29.98	59.15	74.66
Inventory, 5 Yr. CAGR %	25.13	52.3	51.33	46.34	48
Net Property, Plant and Equip., 5 Yr. CAGR %	4.82	10.88	28.27	29.75	29.51
Total Assets, 5 Yr. CAGR %	24.57	28.41	34.56	33.26	48.8
Tangible Book Value, 5 Yr. CAGR %	2.66	3.43	7.31	-14.71	19.7
Common Equity, 5 Yr. CAGR %	2.66	3.13	7.05	-16.18	-22.32
Cash From Operations, 5 Yr. CAGR %	-4.6	4.49	-2.01	-13.64	-8.28
Capital Expenditures, 5 Yr. CAGR %	58.56	-	160.47	30.46	41.64
Levered Free Cash Flow, 5 Yr. CAGR %	-16.94	80.71	9.04	5.83	31.93
Unlevered Free Cash Flow, 5 Yr. CAGR %	-18.56	87.37	-0.91	19.75	78.26